AVNS vs. T

Last updated Jun 24, 2026

AVNS (Avanos Medical, Inc.) and T (AT&T Inc.) are both stocks. AVNS operates in Medical Devices (Healthcare), while T operates in Telecom Services (Communication Services). Over the past 10 years, AVNS returned -2.56%/yr vs 2.70%/yr for T. At a 0.25 correlation, their price movements are largely independent.

Performance

AVNS vs. T - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Avanos Medical, Inc. (AVNS) and AT&T Inc. (T). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, AVNS achieves a 121.99% return, which is significantly higher than T's -6.13% return. Over the past 10 years, AVNS has underperformed T with an annualized return of -2.56%, while T has yielded a comparatively higher 2.70% annualized return.

AVNS

• 1D: 0.12%
• 1M: 1.30%
• YTD: 121.99%
• 6M: 119.07%
• 1Y: 105.86%
• 3Y*: -1.24%
• 5Y*: -8.19%
• 10Y*: -2.56%

T

• 1D: 3.21%
• 1M: -9.70%
• YTD: -6.13%
• 6M: -4.67%
• 1Y: -15.59%
• 3Y*: 20.20%
• 5Y*: 7.06%
• 10Y*: 2.70%

*Multi-year figures are annualized to reflect compound growth (CAGR)

AVNS vs. T - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
AVNS Avanos Medical, Inc.	121.99%	-29.46%	-29.02%	-17.11%	-21.95%	-24.43%	36.14%	-24.76%	-3.01%	24.88%
T AT&T Inc.	-6.13%	13.97%	44.08%	-2.74%	5.76%	-8.09%	-21.37%	45.55%	-22.25%	-4.01%

Correlation

The correlation between AVNS and T is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.08
Correlation (3Y) Calculated over the trailing 3-year period	0.16
Correlation (5Y) Calculated over the trailing 5-year period	0.27
Correlation (10Y) Calculated over the trailing 10-year period	0.26
Correlation (All Time) Calculated using the full available price history since Oct 21, 2014	0.25

The correlation between AVNS and T shifts across timeframes, from 0.07 (1 year) to 0.27 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS AVNS : -$1.99 T : $3.04
PS Ratio AVNS : 1.22 T : 1.31
Total Revenue (TTM) AVNS : $715.90M T : $125.65B
Gross Profit (TTM) AVNS : $353.40M T : $105.41B
EBITDA (TTM) AVNS : -$29.60M T : $54.70B

Return for Risk

AVNS vs. T — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVNS

AVNS Risk / Return Rank: 91
AVNS Sharpe Ratio Rank: 80
AVNS Sortino Ratio Rank: 95
AVNS Omega Ratio Rank: 95
AVNS Calmar Ratio Rank: 92
AVNS Martin Ratio Rank: 92

T

T Risk / Return Rank: 14
T Sharpe Ratio Rank: 13
T Sortino Ratio Rank: 14
T Omega Ratio Rank: 15
T Calmar Ratio Rank: 18
T Martin Ratio Rank: 9

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVNS vs. T - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Avanos Medical, Inc. (AVNS) and AT&T Inc. (T). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	AVNS	T	Difference
Sharpe ratio: Return per unit of total volatility	1.37	-0.69	+2.06
Sortino ratio: Return per unit of downside risk	3.79	-0.89	+4.68
Omega ratio: Gain probability vs. loss probability	1.55	0.90	+0.65
Calmar ratio: Return relative to maximum drawdown	5.07	-0.66	+5.73
Martin ratio: Return relative to average drawdown	13.31	-1.40	+14.71

AVNS vs. T - Sharpe Ratio Comparison

The current AVNS Sharpe Ratio is 1.37, which is higher than the T Sharpe Ratio of -0.69. The chart below compares the historical Sharpe Ratios of AVNS and T, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

AVNS vs. T - Drawdown Comparison

The maximum AVNS drawdown since its inception was -86.39%, which is greater than T's maximum drawdown of -64.15%. Use the drawdown chart below to compare losses from any high point for AVNS and T.

Drawdown Indicators

	AVNS	T	Difference
Max Drawdown Largest peak-to-trough decline	-86.39%	-64.15%	-22.24%
Max Drawdown (1Y) Largest decline over 1 year	-21.01%	-23.57%	+2.56%
Max Drawdown (3Y) Largest decline over 3 years	-62.41%	-23.57%	-38.84%
Max Drawdown (5Y) Largest decline over 5 years	-74.53%	-32.01%	-42.52%
Max Drawdown (10Y) Largest decline over 10 years	-86.39%	-42.35%	-44.04%
Current Drawdown Current decline from peak	-65.68%	-20.80%	-44.88%
Average Drawdown Average peak-to-trough decline	-47.11%	-15.72%	-31.39%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.98%	11.14%	-3.16%

Volatility

AVNS vs. T - Volatility Comparison

The current volatility for Avanos Medical, Inc. (AVNS) is 1.43%, while AT&T Inc. (T) has a volatility of 8.49%. This indicates that AVNS experiences smaller price fluctuations and is considered to be less risky than T based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AVNS	T	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.43%	8.49%	-7.06%
Volatility (6M) Calculated over the trailing 6-month period	56.85%	18.37%	+38.48%
Volatility (1Y) Calculated over the trailing 1-year period	77.65%	22.66%	+54.99%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	47.99%	24.12%	+23.87%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	44.61%	23.79%	+20.82%

Dividends

AVNS vs. T - Dividend Comparison

AVNS has not paid dividends to shareholders, while T's dividend yield for the trailing twelve months is around 4.87%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
AVNS Avanos Medical, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
T AT&T Inc.	4.87%	4.47%	4.87%	6.62%	6.66%	8.46%	7.23%	5.22%	7.01%	5.04%	4.51%	5.46%

Financials

Frequently Asked Questions

Can I hold both AVNS and T in my portfolio?

AVNS and T have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, AVNS or T?

T has higher volatility (8.49%) compared to AVNS (1.43%). In terms of maximum drawdown, AVNS dropped -86.39% vs T's -64.15%.

Which has better risk-adjusted returns?

AVNS currently has the higher Sharpe Ratio (1.37 vs -0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.